We are today announcing that Joy Linton, Bupa’s Group Chief Financial Officer (CFO), will be leaving Bupa in 2021 to take a major new appointment in Australia. Martin Potkins, Bupa’s Corporate Development Director, becomes Interim Group CFO from 1 December 2020 while the search for a permanent successor takes place. Joy and Martin will work together over the period ensuring a smooth transition.
Joy has been Bupa’s Group CFO since 2016. She joined Bupa in 2011 and was Finance and Commercial Director of the Australia and New Zealand Market Unit until she moved to London in 2015. She is returning to Australia to take up the role of CFO at CSL Limited, a global biotechnology company and Australia’s largest quoted company by market capitalisation.
Martin’s appointment is subject to regulatory approval. He is currently Bupa’s Corporate Development Director and Chairman of Bupa Global’s international private medical insurance company based in the Republic of Ireland. He was Bupa’s Corporate Controller from 2015 to 2019. Martin has substantial financial experience having previously held senior roles at Resolution, Friends Life, Prudential and Aviva.
Evelyn Bourke, Group CEO said: “We all wish Joy every success in her new role at CSL. I know she and her family are delighted to be returning home to Australia. I want to recognise her significant contribution over nearly ten years at Bupa, including five years as Group CFO. She’s been an excellent CFO and Board member, and has been key to Bupa’s continued financial strength, including through COVID-19.
“Having previously been Bupa’s Corporate Controller, Martin knows us extremely well. He also brings substantial external experience and finance expertise. I know Joy and Martin will ensure a safe and seamless handover over the coming months.”
Joy Linton, Group CFO said: "I’ve loved my decade at Bupa and it’s been a tremendous privilege to serve as Group CFO. However, my family and I are pleased to be able to return to Australia and I’m looking forward to joining the CSL team next year. In the meantime, I’m fully focused on my role at Bupa, and on ensuring a smooth transition.”